SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001005201-20-000037
Filing Date
2020-05-11
Accepted
2020-05-11 20:23:47
Documents
2
Period of Report
2020-05-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_158924300983323.html 4  
1 FORM 4 wf-form4_158924300983323.xml 4 3810
2 DAWESPOA2020 dawespoa2020.htm EX-24 3235
  Complete submission text file 0001005201-20-000037.txt   8497
Mailing Address 100 SOUTH SAUNDERS RD SUITE 300 LAKE FOREST IL 60045
Business Address 100 SOUTH SAUNDERS RD SUITE 300 LAKE FOREST IL 60045 (224) 419-7106
Assertio Therapeutics, Inc (Issuer) CIK: 0001005201 (see all company filings)

IRS No.: 943229046 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 579 BELLEVUE AVE NEWPORT RI 02840
Business Address
DAWES KAREN A (Reporting) CIK: 0001261506 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-13111 | Film No.: 20866761